Balance Sheet Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:30:00 06/03/2026 GMT			5-day change	1st Jan Change
0.2145 ^USD	+3.62%		-5.80%	-37.97%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

ca387fe.hnfxEeJrbOgFx3R4F_yrla6I6VHss-n99Vp3wgWAk5s.yxzJddNTHLlrjxERZ53R_pntnBWLi4iq2BxArza42fr_E6BEqwUDuzWVHw

Published financial data: VIRAX BIOLABS GROUP LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	124K	-	8.56K	156K	6.33K
Total Revenues	124K	-	8.56K	156K	6.33K
Cost of Goods Sold, Total	133K	-	9.93K	106K	59.4K
Gross Profit	-9.43K	-	-1.36K	50.59K	-53.07K
Selling General & Admin Expenses, Total	515K	1.3M	5.33M	4.59M	4.33M
R&D Expenses	120K	434K	397K	1.56M	1.78M
Other Operating Expenses, Total	635K	1.73M	5.73M	6.16M	6.11M
Operating Income	-645K	-1.73M	-5.73M	-6.11M	-6.16M
Interest Expense, Total	-28.64K	-15.44K	-15.47K	-26.88K	-58.18K
Net Interest Expenses	-28.64K	-15.44K	-15.47K	-26.88K	-58.18K
Other Non Operating Income (Expenses)	266	-753	290K	-17.73K	17.18K
EBT, Excl. Unusual Items	-673K	-1.75M	-5.46M	-6.15M	-6.2M
Asset Writedown	-	-	-	-390K	-
Legal Settlements	-	-	-	-210K	-
Other Unusual Items	-	-	-	12.46K	-
EBT, Incl. Unusual Items	-673K	-1.75M	-5.46M	-6.74M	-6.2M
Income Tax Expense	-	-	-	-	-137K
Earnings From Continuing Operations	-673K	-1.75M	-5.46M	-6.74M	-6.07M
Net Income to Company	-673K	-1.75M	-5.46M	-6.74M	-6.07M
Minority Interest	21.93K	41.04K	269	5.58K	5.98K
Net Income - (IS)	-651K	-1.71M	-5.46M	-6.73M	-6.06M
Net Income to Common Incl Extra Items	-651K	-1.71M	-5.46M	-6.73M	-6.06M
Net Income to Common Excl. Extra Items	-651K	-1.71M	-5.46M	-6.73M	-6.06M
Per Share Items
Net EPS - Basic	-2.71	-1.79	-5.13	-3.36	-1.62
Basic EPS - Continuing Operations	-2.71	-1.79	-5.13	-3.36	-1.62
Basic Weighted Average Shares Outstanding	240K	956K	1.06M	2.01M	3.73M
Net EPS - Diluted	-2.71	-1.79	-5.13	-3.36	-1.62
Diluted EPS - Continuing Operations	-2.71	-1.79	-5.13	-3.36	-1.62
Diluted Weighted Average Shares Outstanding	240K	956K	1.06M	2.01M	3.73M
Normalized Basic EPS	-1.66	-1.1	-3.21	-1.91	-1.04
Normalized Diluted EPS	-1.66	-1.1	-3.21	-1.91	-1.04
Supplemental Items
EBITDA	-	-	-	-6.05M	-5.91M
EBITA	-645K	-1.73M	-5.73M	-6.11M	-6.16M
EBIT	-645K	-1.73M	-5.73M	-6.11M	-6.16M
Total Revenues (As Reported)	124K	-	-	-	-
Effective Tax Rate - (Ratio)	-	-	-	-	2.2
Normalized Net Income	-399K	-1.05M	-3.41M	-3.84M	-3.87M
Interest on Long-Term Debt	-	-	-	26.35K	45.6K
Supplemental Operating Expense Items
Selling and Marketing Expenses	57.2K	13.82K	26.62K	-	-
General and Administrative Expenses	458K	1.29M	5.31M	4.59M	4.33M
Research And Development Expense From Footnotes	120K	434K	397K	1.56M	1.78M
Net Rental Expense, Total	32.14K	-	-	-	-
Imputed Operating Lease Interest Expense	15.81K	-	-	-	-
Imputed Operating Lease Depreciation	16.32K	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	1.73M	-	630K
Stock-Based Comp., Other (Total)	-	-	20K	1.01M	-
Total Stock-Based Compensation	-	-	1.75M	1.01M	630K

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	17.62K	21.76K	9.35M	3.59M	4.23M
Short Term Investments	-	-	49.26K	77.32K	94.19K
Total Cash And Short Term Investments	17.62K	21.76K	9.4M	3.67M	4.32M
Accounts Receivable, Total	928	-	-	-	-
Other Receivables	-	-	-	218K	30.65K
Total Receivables	928	-	-	218K	30.65K
Inventory	21.07K	20.95K	24.1K	306K	189K
Prepaid Expenses	-	6K	208K	190K	351K
Total Current Assets	39.62K	48.71K	9.63M	4.38M	4.89M
Gross Property Plant And Equipment	-	-	-	1.16M	1.93M
Accumulated Depreciation	-	-	-	-103K	-432K
Net Property Plant And Equipment	-	-	-	1.05M	1.49M
Other Intangibles, Total	-	-	178K	49.77K	39.65K
Total Assets	39.62K	48.71K	9.81M	5.48M	6.43M
Liabilities
Accounts Payable, Total	217K	846K	160K	45.63K	56.09K
Accrued Expenses, Total	462K	395K	564K	75.26K	194K
Short-term Borrowings	176K	-	146K	-	370K
Current Portion of Leases	-	-	-	47.96K	52.99K
Unearned Revenue Current, Total	-	-	38.25K	-	-
Other Current Liabilities	16.28K	3.76K	-	-	-
Total Current Liabilities	871K	1.25M	908K	169K	673K
Long-Term Leases	-	-	-	176K	292K
Total Liabilities	871K	1.25M	908K	345K	965K
Common Stock, Total	265	999	1.56K	2.57K	4.34K
Retained Earnings	-4.63M	-6.34M	-11.79M	-18.53M	-24.59M
Comprehensive Income and Other	3.98M	5.36M	20.92M	23.89M	30.28M
Total Common Equity	-651K	-975K	9.13M	5.37M	5.7M
Minority Interest	-181K	-222K	-222K	-228K	-234K
Total Equity	-832K	-1.2M	8.9M	5.14M	5.46M
Total Liabilities And Equity	39.62K	48.71K	9.81M	5.48M	6.43M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	978K	998K	1.79M	2.57M	4.34M
ECS Total Common Shares Outstanding	923K	998K	1.55M	2.57M	4.34M
Book Value / Share	-0.7	-0.98	5.87	2.09	1.31
Tangible Book Value	-651K	-975K	8.95M	5.32M	5.66M
Tangible Book Value Per Share	-0.7	-0.98	5.76	2.07	1.3
Total Debt	176K	0	146K	224K	715K
Net Debt	158K	-21.76K	-9.26M	-3.44M	-3.61M
Debt Equivalent Oper. Leases	257K	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-181K	-222K	-222K	-228K	-234K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	-	-	49.96K
Inventories - Work In Process, Total	-	-	-	-	44.72K
Inventories - Finished Goods, Total	31.07K	30.95K	20.95K	60.38K	46.9K
Machinery, Total	-	-	-	903K	1.49M
Full Time Employees	-	5	11	17	19

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-651K	-1.71M	-5.46M	-6.73M	-6.06M
Depreciation & Amortization - CF	-	-	-	103K	333K
Depreciation & Amortization, Total	-	-	-	103K	333K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	9.91K
Asset Writedown & Restructuring Costs	-	-	-	390K	-
Stock-Based Compensation (CF)	-	290K	1.75M	1.01M	365K
Other Operating Activities, Total	5.06K	-35K	-295K	101K	163K
Change In Accounts Receivable	-928	928	-	-	-
Change In Inventories	-21.07K	121	20.95K	-60.38K	-34.29K
Change In Accounts Payable	83.75K	641K	33.94K	-572K	467K
Change in Unearned Revenues	-	-	38.25K	-38.25K	-
Change in Other Net Operating Assets	176K	2.18K	-275K	-449K	193K
Cash from Operations	-408K	-809K	-4.18M	-6.25M	-4.56M
Capital Expenditure	-	-	-	-952K	-604K
Sale (Purchase) of Intangible assets	-	-	-178K	-212K	-
Cash from Investing	-	-	-178K	-1.16M	-604K
Short Term Debt Issued, Total	-	294K	488K	-	-
Total Debt Issued	-	294K	488K	-	-
Short Term Debt Repaid, Total	-	-	-453K	-168K	-
Long-Term Debt Repaid, Total	-	-	-	-56.37K	-108K
Total Debt Repaid	-	-	-453K	-225K	-108K
Issuance of Common Stock	403K	520K	13.65M	234	5.91M
Other Financing Activities, Total	-	-	-	1.87M	-
Cash from Financing	403K	813K	13.69M	1.65M	5.81M
Miscellaneous Cash Flow Adjustments	-	-1	-	-	-
Net Change in Cash	-4.99K	4.14K	9.33M	-5.76M	640K
Supplemental Items
Cash Interest Paid	-	-	15.47K	6.1K	-
Levered Free Cash Flow	-229K	-548K	-2.71M	-4.99M	-3.25M
Unlevered Free Cash Flow	-211K	-539K	-2.7M	-4.97M	-3.21M
Change In Net Working Capital	-192K	-545K	695K	1.1M	-272K
Net Debt Issued / Repaid	-	294K	34.6K	-225K	-108K

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-1.29K	-2.45K	-72.67	-49.9	-64.68
Return on Total Capital	72.22	116.96	-91.24	-52.89	-66.76
Return On Equity %	65.75	172.53	-141.63	-95.98	-114.47
Return on Common Equity	76.28	210.28	-133.9	-92.92	-109.58
Margin Analysis
Gross Profit Margin %	-7.62	-	-15.94	32.34	-838.21
SG&A Margin	415.83	-	62.31K	2.94K	68.39K
EBITDA Margin %	-	-	-	-3.87K	-93.29K
EBITA Margin %	-520.54	-	-66.96K	-3.9K	-97.34K
EBIT Margin %	-520.54	-	-66.96K	-3.9K	-97.34K
Income From Continuing Operations Margin %	-543.46	-	-63.75K	-4.31K	-95.83K
Net Income Margin %	-525.75	-	-63.75K	-4.3K	-95.74K
Net Avail. For Common Margin %	-525.75	-	-63.75K	-4.3K	-95.74K
Normalized Net Income Margin	-321.95	-	-39.84K	-2.45K	-61.15K
Levered Free Cash Flow Margin	-185.06	-	-31.67K	-3.19K	-51.27K
Unlevered Free Cash Flow Margin	-170.61	-	-31.55K	-3.18K	-50.7K
Asset Turnover
Asset Turnover	3.98	-	0	0.02	0
Fixed Assets Turnover	-	-	-	0.3	0
Inventory Turnover (Average Inventory)	-	-	0.44	0.64	0.32
Short Term Liquidity
Current Ratio	0.05	0.04	10.61	25.94	7.27
Quick Ratio	0.02	0.02	10.35	23.01	6.47
Operating Cash Flow to Current Liabilities	-0.47	-0.65	-4.6	-37	-6.78
Days Outstanding Inventory (Average Inventory)	-	-	828.22	570.18	1.15K
Average Days Payable Outstanding	-	-	14.05K	97.1	291.23
Long Term Solvency
Total Debt/Equity	-21.13	-	1.64	4.36	13.08
Total Debt / Total Capital	-26.78	-	1.62	4.18	11.57
LT Debt/Equity	-	-	-	3.43	5.34
Long-Term Debt / Total Capital	-	-	-	3.29	4.72
Total Liabilities / Total Assets	2.2K	2.56K	9.26	6.29	15.01
EBIT / Interest Expense	-22.5	-112.3	-370.62	-227.18	-105.93
EBITDA / Interest Expense	-	-	-	-223.34	-100.2
(EBITDA - Capex) / Interest Expense	-	-	-	-258.78	-110.58
Total Debt / EBITDA	-	-	-	-0.04	-0.12
Net Debt / EBITDA	-	-	-	0.57	0.62
Total Debt / (EBITDA - Capex)	-	-	-	-0.03	-0.11
Net Debt / (EBITDA - Capex)	-	-	-	0.49	0.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.97	-	-	1.73K	-95.95
Gross Profit, 1 Yr. Growth %	-120.62	-	-	-3.81K	-204.9
EBITDA, 1 Yr. Growth %	-	-	-	-	-2.4
EBITA, 1 Yr. Growth %	-1.03	168.98	230.67	6.51	0.93
EBIT, 1 Yr. Growth %	-1.03	168.98	230.67	6.51	0.93
Earnings From Cont. Operations, 1 Yr. Growth %	-9	160.04	211.9	23.48	-9.97
Net Income, 1 Yr. Growth %	-8.37	162.5	219.37	23.38	-9.98
Normalized Net Income, 1 Yr. Growth %	-7.97	164.05	224.03	6.78	0.86
Diluted EPS Before Extra, 1 Yr. Growth %	-60.23	-33.99	185.23	-34.56	-51.58
Inventory, 1 Yr. Growth %	-	-0.57	15.01	1.17K	2.36
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	41.71
Total Assets, 1 Yr. Growth %	75.24	22.93	20.05K	-44.11	17.19
Tangible Book Value, 1 Yr. Growth %	-38.39	49.78	-1.02K	-40.58	6.38
Common Equity, 1 Yr. Growth %	-38.39	49.78	-1.04K	-41.2	6.14
Cash From Operations, 1 Yr. Growth %	921.17	37.09	414.76	49.46	-26.95
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-36.6
Levered Free Cash Flow, 1 Yr. Growth %	-	139.34	963.1	82.72	-32.27
Unlevered Free Cash Flow, 1 Yr. Growth %	-	155.06	1K	82.75	-32.79
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-73.71	-	-14
Gross Profit, 2 Yr. CAGR %	-	-	-61.96	-	523.51
EBITA, 2 Yr. CAGR %	-	63.16	198.23	87.67	3.68
EBIT, 2 Yr. CAGR %	-	63.16	198.23	87.67	3.68
Earnings From Cont. Operations, 2 Yr. CAGR %	-	53.83	184.79	96.24	5.44
Net Income, 2 Yr. CAGR %	-	55.09	189.54	98.51	5.39
Normalized Net Income, 2 Yr. CAGR %	-	55.89	192.51	90.96	3.78
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-48.77	37.72	37.01	-43.74
Inventory, 2 Yr. CAGR %	-	-	6.93	281.95	179.88
Total Assets, 2 Yr. CAGR %	-	46.77	1.47K	961.1	-19.07
Tangible Book Value, 2 Yr. CAGR %	-	-3.94	270.83	133.57	-20.49
Common Equity, 2 Yr. CAGR %	-	-3.94	274.51	134.66	-21
Cash From Operations, 2 Yr. CAGR %	-	4.24	166.12	177.87	4.49
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	243.96	344.78	9.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	257.6	352.78	8.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-55.91	8.1	-
Gross Profit, 3 Yr. CAGR %	-	-	-68.98	75.03	-
EBITA, 3 Yr. CAGR %	-	-	106.48	111.6	52.62
EBIT, 3 Yr. CAGR %	-	-	106.48	111.6	52.62
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	94.7	115.55	51.35
Net Income, 3 Yr. CAGR %	-	-	97.31	117.88	52.51
Normalized Net Income, 3 Yr. CAGR %	-	-	98.95	112.75	54.36
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-8.97	7.47	-3.18
Inventory, 3 Yr. CAGR %	-	-	-	143.88	108.07
Total Assets, 3 Yr. CAGR %	-	-	657.12	417.28	409.1
Tangible Book Value, 3 Yr. CAGR %	-	-	103.86	101.42	79.71
Common Equity, 3 Yr. CAGR %	-	-	105.21	102.04	80.13
Cash From Operations, 3 Yr. CAGR %	-	-	77.72	119.56	78.01
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	179.19	134.39
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	186.55	136.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-42.4
Gross Profit, 5 Yr. CAGR %	-	-	-	-	3.01
EBITA, 5 Yr. CAGR %	-	-	-	-	56.75
EBIT, 5 Yr. CAGR %	-	-	-	-	56.75
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	52.34
Net Income, 5 Yr. CAGR %	-	-	-	-	53.53
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	54.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-24.91
Total Assets, 5 Yr. CAGR %	-	-	-	-	209.56
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	39.88
Common Equity, 5 Yr. CAGR %	-	-	-	-	40.08
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	43.71